M A Moore Selected Research

M A Moore Research Topics

Disease

7	Neoplasms (Cancer) 11/2001 - 04/2000
3	Leukemia 09/2001 - 02/2000
1	Thrombocytopenia (Thrombopenia) 12/2001
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2001
1	Neoplasm Metastasis (Metastasis) 08/2001
1	Breast Neoplasms (Breast Cancer) 08/2001
1	Inflammation (Inflammations) 07/2001
1	Splenomegaly 05/2001
1	Hypertension (High Blood Pressure) 01/2001
1	Vascular Remodeling 01/2001
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 12/2000
1	Polyploidy 12/2000
1	Carcinogenesis 04/2000
1	Colonic Neoplasms (Colon Cancer) 04/2000
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2000
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2000
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2000
1	Polycythemia Vera 02/2000
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2000

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2001 - 08/2000
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2001 - 08/2000
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2001 - 08/2000
2	Matrix Metalloproteinases (MMPs)IBA 08/2001 - 12/2000
2	Monoclonal AntibodiesIBA 05/2001 - 11/2000
2	CD40 Ligand (CD40L)IBA 11/2000 - 07/2000
1	anagrelide (Agrylin)FDA LinkGeneric 12/2001
1	matrigelIBA 11/2001
1	Angiogenesis InhibitorsIBA 09/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2001
1	LigandsIBA 08/2001
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2001
1	Chemokine ReceptorsIBA 08/2001
1	CollagenIBA 07/2001
1	Pharmaceutical PreparationsIBA 01/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2001
1	Antihypertensive Agents (Antihypertensives)IBA 01/2001
1	DiureticsIBA 01/2001
1	Angiotensin Receptor AntagonistsIBA 01/2001
1	Matrix Metalloproteinase InhibitorsIBA 12/2000
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2000
1	Proteins (Proteins, Gene)FDA Link 08/2000
1	Messenger RNA (mRNA)IBA 08/2000
1	IMC1C11IBA 08/2000
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2000
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 05/2000
1	Complementary DNA (cDNA)IBA 05/2000
1	CC ChemokinesIBA 05/2000
1	Whey ProteinsIBA 04/2000
1	Conjugated Linoleic AcidsIBA 04/2000
1	LactoferrinIBA 04/2000
1	FatsIBA 04/2000
1	CalciumIBA 04/2000
1	Calcitriol (Calcijex)FDA LinkGeneric 04/2000
1	AzoxymethaneIBA 04/2000
1	Interleukin-6 (Interleukin 6)IBA 02/2000
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2000
1	CytokinesIBA 02/2000
1	Stem Cell FactorIBA 02/2000
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2000
1	Erythropoietin FDA Link 02/2000
1	Interleukin-3 (Interleukin 3)IBA 02/2000

Therapy/Procedure

3	Therapeutics 09/2001 - 11/2000
2	Immunotherapy 11/2000 - 07/2000
1	Transplantation 11/2001
1	Heterologous Transplantation (Xenotransplantation) 08/2000
1	Chemoprevention 04/2000